1. Home
  2. SMG vs BLLN Comparison

SMG vs BLLN Comparison

Compare SMG & BLLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Scotts Miracle-Gro Company (The)

SMG

Scotts Miracle-Gro Company (The)

HOLD

Current Price

$60.99

Market Cap

3.5B

Sector

Industrials

ML Signal

HOLD

BLLN

BillionToOne Inc.

N/A

Current Price

$83.22

Market Cap

3.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SMG
BLLN
Founded
1868
2016
Country
United States
United States
Employees
N/A
713
Industry
Agricultural Chemicals
Medical Specialities
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.5B
3.5B
IPO Year
2012
N/A

Fundamental Metrics

Financial Performance
Metric
SMG
BLLN
Price
$60.99
$83.22
Analyst Decision
Buy
Buy
Analyst Count
6
7
Target Price
$72.67
$126.71
AVG Volume (30 Days)
851.7K
295.7K
Earning Date
04-29-2026
03-04-2026
Dividend Yield
4.34%
N/A
EPS Growth
504.92
N/A
EPS
N/A
N/A
Revenue
$3,016,500,000.00
N/A
Revenue This Year
N/A
$45.89
Revenue Next Year
$2.54
$30.17
P/E Ratio
N/A
N/A
Revenue Growth
6.17
N/A
52 Week Low
$45.61
$61.96
52 Week High
$72.35
$138.70

Technical Indicators

Market Signals
Indicator
SMG
BLLN
Relative Strength Index (RSI) 41.54 57.40
Support Level $58.67 $80.39
Resistance Level $64.72 $86.01
Average True Range (ATR) 2.27 5.45
MACD -0.35 1.32
Stochastic Oscillator 15.28 88.13

Price Performance

Historical Comparison
SMG
BLLN

About SMG Scotts Miracle-Gro Company (The)

Scotts Miracle-Gro is the largest purveyor of home lawn and gardening products in the US. The company sells a broad range of lawncare products, including grass seed, fertilizer, and lawn-related weed, animal, and disease control. US consumer typically generates the vast majority of companywide revenue and profits. Its lawncare and gardening products are well-recognized brands in the US, including Scotts, Miracle-Gro, Roundup, Ortho, and Tomcat.

About BLLN BillionToOne Inc.

BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.

Share on Social Networks: